Company profile

SWISS MEDENDI SA

Swiss Medendi is the only company to offer a specific, disposable, patent granted medical device for a safe chemotherapy infusion. HC100 protects patient’s vessels from chemical phlebitis, sclerosis and necrosis. It reduces and or eliminates injuries and complications associated with today’s devices. No other specific technology is available neither efficient as our in a close and sterile system. There are no variations to chemotherapy protocols, and end users such as hospitals, GPOs and Medical practices, may save over 77% of their costs comparing with today’s methods and devices, we are bringing patient’s quality of life to levels never seen before.

More news about SWISS MEDENDI SA

30.10.2015 13:59

Start-ups selected for 5th Investors Forum St. Gallen

Please login or
register to use the
awards follow feature
03.07.2014 07:59

Preisträger der W. A. de Vigier Stiftung: Swiss Medendi

Please login or
register to use the
awards follow feature
28.02.2014 12:38

First Swiss Venture Day in 2014 on the horizon

Please login or
register to use the
awards follow feature
SWISS MEDENDI SA

Founded
2012

Kanton
TI

Homepage

rss